"I think this answers a lot of questions that many of us have had about this illness for a long time. By focusing on both psychiatric and metabolic factors, we might be able to do a much better job in serving our patients."
Cynthia Bulik, a professor and the founding director of the University of North Carolina at Chapel Hill's UNC Center of Excellence for Eating Disorders, saying that anorexia nervosa is not just a psychiatric disorder, but a metabolic one as well, a conclusion derived from a genome wide association study that she and her team have published in the July 15, 2019, issue of Nature Genetics

"Over the past 10 years in Asia, the number of life sciences and health care companies listed on stock exchanges has steadily increased by about 8 percent. Shanghai just launched a Nasdaq-like exchange. It's expected to allow pre-revenue biotech companies to list. As of last week, about 150 companies have applied to raise funds on the stock market through IPOs."
Katherine Andersen, head of life science and health care relationship banking at Silicon Valley Bank, speaking at the 2019 BIO Asia-Taiwan Conference and Exhibition

"With 10 mid- to late-stage readouts over the next 18 months we believe we are poised to reinforce our core franchises in MS and neuromuscular disorders, build for their depth in neuroscience portfolio and follow the science into emerging areas."
Michael Ehlers, executive vice president and head of R&D, Biogen Inc., speaking on a conference call to discuss the company's second-quarter financial results, which, thanks to growing sales of its multiple sclerosis therapies and lower R&D expenses, led the company to beat both top- and bottom-line expectations